Concepedia

Maggie Lewis

ML

7

Publications

1.7K

Citations

7

H-Index

2009

Active since

Affiliations

Novavax (United States)(Current)

University of Maryland, Baltimore

Baylor College of Medicine

Maggie Lewis is an author at Novavax (United States) specializing in immunodominance, medicine, and vaccine development.

Top concepts

Publications per year

2009–2024

7

Publications

7

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech, Gary Albert, Iksung Cho et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

Raxibacumab for the Treatment of Inhalational Anthrax

Thi-Sau Migone, G. Mani Subramanian, John Zhong et al. · New England Journal of Medicine · 2009 · 286 citations · Full text

Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes

Gale Smith, Ye Liu, David C. Flyer et al. · Vaccine · 2017 · 52 citations · Full text

Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults

Louis Fries, Iksung Cho, Verena Krähling et al. · The Journal of Infectious Diseases · 2019 · 46 citations · Full text

First-in-Human Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech, Gregory M. Glenn, Gary Albert et al. · 2020 · 43 citations · Full text

, , +20

Rows per page

1–5 of 7